{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"8.0","value":"27.4"},{"groupId":"OG001","spread":"9.6","value":"37.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}],"units":"Participants"}],"description":"Comparison of MSG and placebo 18F-DCFPyL renal accumulation measured by the maximal standardized uptake values corrected for lean body mass (SULmax). For determination of renal uptake, regions of interest will be drawn around the kidneys, using a standardized contouring method, to measure the SULmax. The average SULmax in the organs will be used for this analysis.","dispersionType":"Standard Deviation","groups":[{"description":"Participants who received MSG dissolved in juice, in a fasting state, prior to the administration of 18F-DCFPyL, in either the first or second PET/CT scan.","id":"OG000","title":"18F-DCFPyL PET/CT Scan With MSG Drink"},{"description":"Participants who received the Placebo juice, in a fasting state, prior to the administration of 18F-DCFPyL, in either the first or second PET/CT scan.","id":"OG001","title":"18F-DCFPyL PET/CT Scan With Placebo Drink"}],"paramType":"MEAN","populationDescription":"All participants who received at least one dose of each intervention and completed all study visits were included in the efficacy analysis.","reportingStatus":"POSTED","timeFrame":"scan with MSG and 3-7 days later, scan with Placebo (or vice versa)","title":"Renal Maximal Standardized Uptake Values Corrected for Lean Body Mass (SULmax) for 18F-DCFPyL","type":"SECONDARY","unitOfMeasure":"SULmax"}